Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelogenous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05945849
What this trial is testing

CD33KO-HSPC Infusion Followed by CART-33 Infusion(s) for Refractory/Relapsed AML

Who this might be right for
Leukemia, Myeloid, Acute
University of Pennsylvania 16
Testing effectiveness (Phase 2)Study completedNCT04992949
What this trial is testing

Evaluation of CPX-351 Monotherapy in Acute Myeloid Leukemia Secondary to Myeloproliferative Neoplasm

Who this might be right for
Acute Myeloid LeukemiaMyeloproliferative Syndrome
French Innovative Leukemia Organisation 42
Testing effectiveness (Phase 2)WithdrawnNCT06085638
What this trial is testing

Phase I/II Study of SY-1425 (Tamibarotene) in Combination With Azacitidine and Venetoclax for Patients With Chronic Myelomonocytic Leukemia

Who this might be right for
Chronic Myelomonocytic Leukemia
M.D. Anderson Cancer Center
Not applicableNot Yet RecruitingNCT05440747
What this trial is testing

Treatment Free Remission (TFR) in CML Patients （CML-CP）Study

Who this might be right for
Chronic Myeloid LeukemiaTreatment-free Remission
Guangdong Provincial People's Hospital 203
Not applicableStudy completedNCT02873949
What this trial is testing

Analysis of Soluble TREM (Triggering Receptor Expressed on Myeloid Cells)-1 and -2 in Crevicular Fluid and Associated Bacterial Flora in Patients Affected by Periodontitis

Who this might be right for
Periodontitis
Central Hospital, Nancy, France 60
Large-scale testing (Phase 3)Ended earlyNCT00109538
What this trial is testing

Study of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978AM3)(TERMINATED)

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicMyelodysplasia+1 more
Merck Sharp & Dohme LLC 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT05656248
What this trial is testing

Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms

Who this might be right for
Myeloid Neoplasm
St. Jude Children's Research Hospital 25
Large-scale testing (Phase 3)Not Yet RecruitingNCT07735117
What this trial is testing

Mitoxantrone Hydrochloride Liposome, Cytarabine, G-CSF Plus Venetoclax vs. Azacitidine Plus Venetoclax for MDS-IB2 and Secondary/Elderly AML

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndromes (MDS)
Ruijin Hospital 168
Not applicableStudy completedNCT00969891
What this trial is testing

Study of Dosage Individualisation for the Treatment of Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Mikkel Krogh-Madsen 23
Not applicableEnded earlyNCT00513318
What this trial is testing

Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplasiaAcute Lymphoblastic Leukemia+4 more
University of California, San Francisco 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT06858618
What this trial is testing

FCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid Neoplasms

Who this might be right for
SafetyAntitumor ActivityPK Profile
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 47
Testing effectiveness (Phase 2)Study completedNCT00797758
What this trial is testing

Reduction of Cord Blood Transplantation Toxicity in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Assistance Publique - Hôpitaux de Paris 76
Large-scale testing (Phase 3)Looking for participantsNCT05726110
What this trial is testing

Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed or Refractory Acute Myeloid Leukemia
Shanxi Bethune Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00065143
What this trial is testing

Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

Who this might be right for
Leukemia, MyeloidMyelodysplastic Syndromes
M.D. Anderson Cancer Center 60
Not applicableLooking for participantsNCT07263074
What this trial is testing

Considering alloHCT: Opportunities for Patient Reflection During Decision-Making Via Digital Stories

Who this might be right for
Myeloid Malignancy
University of Rochester 120
Large-scale testing (Phase 3)Study completedNCT00136084
What this trial is testing

Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia

Who this might be right for
Leukemia, Myelocytic, Acute
St. Jude Children's Research Hospital 238
Early research (Phase 1)Looking for participantsNCT07020533
What this trial is testing

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+9 more
City of Hope Medical Center 46
Testing effectiveness (Phase 2)Ended earlyNCT01573247
What this trial is testing

Safety Study of AKN-028 in Patients With Acute Myelogenous Leukemia

Who this might be right for
Acute Myeloid Leukemia
Akinion Pharmaceuticals AB 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT04980885
What this trial is testing

A Trial of AK117 (Anti-CD47 Antibody) in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Akeso 68
Early research (Phase 1)Study completedNCT05470140
What this trial is testing

WU-NK-101 in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Allotera Therapeutics 9
Next Page